Guidance
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Published guidance on this topic (29)
- New guidance in the last 6 months (5)
- Updated guidance in the last 6 months (0)
- In development guidance (5)
NICE advice
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (6)
- New advice in the last 6 months (0)
- Updated advice in the last 6 months (0)
- In development advice (0)
NICE Pathways
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject.
Guidance by programme
-
NICE guidelines (2)
Review the evidence across broad health and social care topics.
-
Technology appraisal guidance (7)
Reviews the clinical and cost-effectiveness of new treatments.
-
Diagnostics guidance (1)
Review new diagnostic technologies for adoption in the NHS.
-
Highly specialised technologies guidance (1)
Review clinical and cost-effectiveness of specialised treatments.
-
Interventional procedures guidance (23)
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
-
Medical technologies guidance (2)
Reviews new medical devices for adoption in the NHS.
Advice by programme
-
Medtech innovation briefings (6)
Review the evidence and likely costs of medical devices and technologies.
Products being developed or updated
-
In consultation (1)
Guidance and quality standards open for consultation.
-
In development (5)
Guidance, quality standards and advice being developed.
-
Proposed (2)
Technology appraisal guidance which has been proposed for development.
Get involved
Comment on guidance in development
Current guidance in consultation
News on this topic
Spinraza access agreement extended
More children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with Spinraza after NICE today (3 July) published amended draft guidance following a proposal for extending the terms of the managed access agreement (MAA) between NHS England and Biogen for funding it.
Putting guidance into practice
Shared learning
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 7 shared learning examples for this topic:
-
Improving educational resources for people with back pain in Sheffield
-
Best evidence for a better back (BE FABB) - A triage, assessment and education service for patients with low back pain with or without sciatica
-
The Integrated Pain and Spinal Service (IPASS): A unique, integrated and collaborative approach to persistent pain management